GlassScriptPhysician profile
Gautam Kedia
NPI 1518179373
$18,141.08
in general payments reported to CMS, 2019-2025
56 companies · $2,328 in 2025
The $2,328 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,795 · 2020: $1,808 · 2021: $1,468 · 2022: $2,842 · 2023: $3,569 · 2024: $2,332 · 2025: $2,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,423 · Travel and Lodging: $569 · Education: $144 · Debt Forgiveness: $93.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,423.39 |
| Travel and Lodging | $568.66 |
| Education | $143.98 |
| Debt Forgiveness | $93.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,997.20 | 2019-2025 | Watchman Flx, Watchman Access System, Rotapro |
| Abbott Laboratories | $1,745.50 | 2019-2025 | Cardiomems, Aveir, Mitraclip |
| Novartis Pharmaceuticals Corporation | $1,083.04 | 2019-2025 | |
| Heartflow, INC. | $1,058.91 | 2022-2025 | Ffrct |
| Boehringer Ingelheim Pharmaceuticals, INC. | $912.42 | 2019-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $841.02 | 2019-2025 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $824.49 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $799.92 | 2021-2025 | Verquvo, Winrevair |
| Astrazeneca Pharmaceuticals LP | $778.49 | 2019-2025 | Wainua, Farxiga, Brilinta |
| Amgen INC. | $776.37 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $600.96 | 2019-2025 | |
| Bardy Diagnostics, INC. | $595.00 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $551.41 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $539.69 | 2019-2025 | Eliquis, Camzyos |
| Baxter Healthcare | $496.49 | 2022-2024 | Hillrom - Carnation Ambulatory Monitor |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $489.75 | 2021-2025 | Closurefast, Venaseal, Corevalve Evolut R |
| Kestra Medical Technology Services, INC. | $338.18 | 2023-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $290.33 | 2019-2023 | |
| Edwards Lifesciences Corporation | $284.14 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Chiesi USA, INC. | $276.34 | 2019-2025 | Cleviprex, Kengreal |
| Amarin Pharma, INC. | $256.12 | 2019-2022 | |
| Medtronic Vascular, INC. | $216.42 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $210.79 | 2020-2025 | |
| Biotronik INC. | $199.39 | 2019-2024 | |
| Astellas Pharma US INC | $154.37 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $151.46 | 2022-2025 | Amvuttra |
| Lundbeck LLC | $142.97 | 2019-2020 | |
| Biosense Webster, INC. | $134.67 | 2025 | Carto 3 |
| Atricure, INC. | $133.78 | 2022-2024 | |
| Novo Nordisk INC | $123.73 | 2024-2025 | Ozempic |
| Regeneron Healthcare Solutions, INC. | $114.17 | 2019-2025 | Evkeeza |
| Kiniksa Pharmaceuticals International, Plc | $109.53 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $108.02 | 2021-2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $102.28 | 2023-2024 | Inpefa |
| Esperion Therapeutics, INC. | $85.16 | 2020-2023 | Nexletol |
| Bridgebio Pharma, INC. | $83.60 | 2025 | Attruby |
| Siemens Medical Solutions USA, INC. | $68.48 | 2022 | |
| Gilead Sciences, INC. | $67.48 | 2019 | |
| Tactile Systems Technology INC | $60.08 | 2019-2020 | |
| Philips North America LLC | $51.36 | 2022-2023 | |
| Nevro Corp. | $42.47 | 2023 | Senza |
| Impulse Dynamics (USA) INC. | $28.07 | 2022 | |
| Daiichi Sankyo INC. | $24.85 | 2023 | Injectafer |
| Medicure Pharma INC. | $23.65 | 2019 | |
| Bard Peripheral Vascular, INC. | $21.53 | 2023 | Rotarexs 6 F X 135 Cm |
| Abiomed | $20.41 | 2020 | |
| Itamar Medical INC | $19.20 | 2022 | |
| Cardiovascular Systems INC. | $17.37 | 2019 | |
| Irhythm Technologies, INC. | $15.28 | 2023 | Zio Xt Patch |
| Kowa Pharmaceuticals America, INC. | $14.41 | 2020 | |
| Inspire Medical Systems, INC. | $13.77 | 2025 | Inspire |
| Cook Medical LLC | $13.42 | 2024 | Zilver Ptx |
| Scpharmaceuticals INC. | $12.87 | 2023 | |
| Janssen Biotech, INC. | $12.26 | 2020 | |
| Vivaquant INC, Dba Rhythm Express | $8.01 | 2025 | Rhythm Express |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gautam Kedia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.